Coave Therapeutics (“Coave”), a company redefining targeted gene therapy with a best-in-class pipeline powered by ...

The U.S. Food and Drug Administration today approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy. Otarmeni is indicated for the ...

Richland County Vector Control crews will soon begin spraying for mosquitoes as part of the County's annual effort to protect ...

The U.S. Food and Drug Administration today approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy. Otarmeni ...

Zilliz, the creator of Milvus -- the world's most widely adopted open-source vector database with over 43,000 GitHub stars and more than 10,000 enterprise deployments -- has been recognized as a ...

Eli Lilly is picking up its second in vivo CAR-T company of the year, paying $3.25 billion in upfront cash for Kelonia ...

The CDC is reporting that ER visits for tick bites are higher than usual. The CDC says that, according to its Bite Tracker, ...

Turkey’s trajectory is not dependent on the outcome of the Iranian case - it is a function of its desire to claim leadership ...

The Big Apple is about to be bled dry — and not just because of ferocious tax hikes. This spring and summer, NYC could see an ...

Participants will get their hands dirty digging soil samples and more as they attend GALS, a mini-series of science programs ...

Approved Thursday via the FDA's Commissioner’s National Priority Voucher program, Otarmeni is the first gene therapy for ...

The FDA has granted an accelerated approval for Otarmeni (lunsotogene parvec-cwha), the first gene therapy to treat patients ...